http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20081343-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1e7e3a08912452da9c7067910688362 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate | 2007-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6e30978cd908b7ef118a59de0ecbc61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_656176d77cf1e4a039fdc83be19be9b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b32f82eeeaed195ff143be9441a3398 |
| publicationDate | 2008-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PE-20081343-A1 |
| titleOfInvention | SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF IBANDRONIC ACID OR A SALT OR A PHARMACEUTICALLY ACCEPTABLE HYDRATE OF THE SAME, PROCEDURE FOR THE PREPARATION OF SAID COMPOSITION BY DIRECT COMPRESSION, PHARMACEUTICAL FORMULATIONS THAT |
| abstract | REFERRED TO AN ORAL SOLID PHARMACEUTICAL COMPOSITION IN THE FORM OF A UNIT DOSAGE THAT INCLUDES IBANDRONIC ACID OR A SALT OF THE SAME IN AN AMOUNT OF 30% TO 37% BY WEIGHT OF THE DOSAGE, A THINNER IN AN AMOUNT OF 55% TO 65%, AN AGENT DISINTEGRANT IN AN AMOUNT OF 0.5% TO 1.5%, A LUBRICANT IN AN AMOUNT OF 4.5% TO 5.5%. THE THINNER MAY BE MICROCRYSTALLINE CELLULOSE, POWDERED CELLULOSE, MICROFINE CELLULOSE, AMONG OTHERS; THE LUBRICANT MAY BE SODIUM STEARYL FUMARATE, TALC, OIL, AMONG OTHERS. IT IS ALSO REFERRED TO A PREPARATION PROCESS |
| priorityDate | 2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.